Beverly Hills Private Wealth, LLC

Position in JNJ — Johnson & Johnson

CIK 1965710 BEVERLY HILLS, CA

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$3,612,722

-$2,014,775 QoQ

Shares Held

14,225

-38.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.85%

of 13F equity value

Holder Rank

#1,857

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Beverly Hills Private Wealth, LLC holds $13,330,659 across 9 Drug Manufacturers - General names. JNJ ranks #1 (27.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	14,225	$3,612,722
2	NVO	Novo Nordisk A S	63,562	$3,047,161
3	GSK	GSK plc	33,201	$1,740,395
4	ABBV	AbbVie Inc.	6,164	$1,551,108
5	LLY	ELI LILLY & Co	994	$1,192,233
6	AMGN	Amgen Inc	2,339	$846,998
7	MRK	Merck & Co., Inc.	5,600	$719,600
8	NVS	Novartis AG	2,596	$406,845

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,612,722	14,225	-38.2%	Shares	Other	2026-08-07
2026-03-31	$5,627,497	23,022	-0.8%	Shares	Defined	2026-05-04
2025-12-31	$4,804,964	23,218	-1.4%	Shares	Sole	2026-02-17
2025-09-30	$4,366,453	23,549	-5.7%	Shares	Sole	2025-11-10
2025-06-30	$3,816,151	24,983	-2.1%	Shares	Sole	2025-07-29
2025-03-31	$4,232,066	25,519	+0.8%	Shares	Sole	2025-04-30
2024-12-31	$3,660,185	25,309	-3.3%	Shares	Sole	2025-02-14
2024-09-30	$4,240,459	26,166	-6.7%	Shares	Sole	2024-11-12
2024-06-30	$4,100,077	28,052	-1.1%	Shares	Sole	2024-08-08
2024-03-31	$4,487,846	28,370	+3.3%	Shares	Sole	2024-05-09
2023-12-31	$4,304,704	27,464	-7.8%	Shares	Sole	2024-01-30
2023-09-30	$4,640,568	29,795	-45.2%	Shares	Sole	2023-11-08
2023-06-30	$8,997,998	54,362	+64.5%	Shares	Sole	2023-08-10
2023-03-31	$5,121,355	33,041	+54.8%	Shares	Sole	2023-05-04
2022-12-31	$3,770,770	21,346	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.